InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by FRATES JAMES M, Director. Director active across 2 companies, notably Sage Therapeutics, Inc.. Aggregated, 19 reports have been published. Split: 3 buys · 6 sells. Total volume traded: €1.4m. Activity tracked since 16 June 2021. The latest transaction was disclosed on 31 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations19 total
10,896 shares@ US$3.46971.8% of flowCommon StockSEC:0000950170-25-049581:0
68,420 shares0Common StockSEC:0000950170-25-036707:0
40,000 shares@ US$2.53424.8% of flowCommon StockSEC:0000950170-24-106910:0
Canonical exit: 11 Dec 2024 (T+90)
18,165 shares@ US$6.886.1% of flowCommon StockSEC:0000950170-24-104191:0
91,180 shares0Common StockSEC:0000950170-24-045698:0
1,792 shares@ US$18.72791.6% of flowCommon StockSEC:0000950170-24-027918:0
40,000 shares0Common StockSEC:0000950170-24-022434:0
2,716 shares@ US$16.32812.1% of flowCommon StockSEC:0000950170-24-003984:0
11,072 shares0Common StockSEC:0000950170-23-058113:0
18,165 shares@ US$6.886.1% of flowCommon StockSEC:0000950170-23-044381:0
32,500 shares@ US$6.8810.9% of flowCommon StockSEC:0000899243-23-013289:0
19,482 shares0Common StockSEC:0000899243-23-011781:0
32,500 shares@ US$6.8811.1% of flowCommon StockSEC:0000899243-23-009602:0
30,796 shares@ US$31.859348.9% of flowCommon StockSEC:0000899243-23-009168:0
1,836 shares@ US$36.07893.3% of flowCommon StockSEC:0000899243-23-001523:0
822 shares@ US$36.78881.5% of flowCommon StockSEC:0000899243-23-001523:1
5,000 shares@ US$6.881.7% of flowCommon StockSEC:0000899243-23-000755:0
1,810 shares@ US$55.10250.0% of flowCommon StockSEC:0001562180-21-004347
Canonical exit: 14 Sept 2021 (T+90)
1,810 shares@ US$55.10250.0% of flowCommon StockSEC:0001562180-21-004347:0
Canonical exit: 14 Sept 2021 (T+90)
19 of 19 declarations
About FRATES JAMES M
James M. Frates is a Board Member at Sage Therapeutics, Inc. He plays a vital role in overseeing the company's activities and strategic direction. With extensive experience in the healthcare sector, he contributes to policy development that fosters innovation and efficiency. His commitment to the company's mission is crucial for its growth and success.
